Literature DB >> 23449887

Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.

Erin E O'Leary1, Anna M Mazurkiewicz-Muñoz, Lawrence S Argetsinger, Travis J Maures, Hung T Huynh, Christin Carter-Su.   

Abstract

The tyrosine kinase Janus kinase 2 (JAK2) is activated by many cytokine receptors, including receptors for GH, leptin, and erythropoietin. However, very few proteins have been identified as binding partners for JAK2. Using a yeast 2-hybrid screen, we identified steroid-sensitive gene-1 (SSG1)/coiled-coil domain-containing protein 80 (Ccdc80) as a JAK2-binding partner. We demonstrate that Ccdc80 preferentially binds activated, tyrosyl-phosphorylated JAK2 but not kinase-inactive JAK2 (K882E) in both yeast and mammalian systems. Ccdc80 is tyrosyl phosphorylated in the presence of JAK2. The binding of Ccdc80 to JAK2 occurs via 1 or more of the 3 DUDES/SRPX (DRO1-URB-DRS-Equarin-SRPUL/sushi repeat containing protein, x-linked) domain 5 domains of Ccdc80. Mutagenesis of the second DUDES domain suggests that the N-terminal third of the DUDES domain is sufficient for JAK2 binding. Ccdc80 does not alter the kinase activity of JAK2. However, Ccdc80 increases GH-dependent phosphorylation of Stat (signal transducer and activator of transcription) 5b on Tyr699 and substantially enhances both basal and GH-dependent phosphorylation/activation of Stat3 on Tyr705. Furthermore, Ccdc80 belongs to the group of proteins that function both in the intracellular compartment and are secreted. Secreted Ccdc80 associates with the extracellular matrix and is also found in the medium. A substantial portion of the Ccdc80 detected in the medium is cleaved. Finally, consistent with the DUDES domain serving as a JAK2-binding domain, we also demonstrate that another protein that contains a DUDES domain, SRPX2, binds preferentially to the activated tyrosyl-phosphorylated form of JAK2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449887      PMCID: PMC3607695          DOI: 10.1210/me.2011-1275

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  68 in total

1.  TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.

Authors:  M P Myers; J N Andersen; A Cheng; M L Tremblay; C M Horvath; J P Parisien; A Salmeen; D Barford; N K Tonks
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

Review 2.  Growth factors in the extracellular matrix.

Authors:  J Taipale; J Keski-Oja
Journal:  FASEB J       Date:  1997-01       Impact factor: 5.191

3.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

4.  DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.

Authors:  Guido T Bommer; Claudia Jäger; Eva-Maria Dürr; Sebastian Baehs; Sören T Eichhorst; Thomas Brabletz; Gang Hu; Thomas Fröhlich; Georg Arnold; Dagmar C Kress; Burkhard Göke; Eric R Fearon; Frank T Kolligs
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

5.  Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity.

Authors:  Lawrence S Argetsinger; Jeanne A Stuckey; Scott A Robertson; Rositsa I Koleva; Joel M Cline; Jarrod A Marto; Martin G Myers; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2010-03-19

6.  Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells.

Authors:  Roberta Visconti; Filippo Schepis; Rodolfo Iuliano; Giovanna Maria Pierantoni; Li Zhang; Francesca Carlomagno; Caterina Battaglia; Maria Luisa Martelli; Francesco Trapasso; Massimo Santoro; Alfredo Fusco
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

7.  Bidirectional modulation of adipogenesis by the secreted protein Ccdc80/DRO1/URB.

Authors:  Frédéric Tremblay; Tracy Revett; Christine Huard; Ying Zhang; James F Tobin; Robert V Martinez; Ruth E Gimeno
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

8.  Equarin, a novel soluble molecule expressed with polarity at chick embryonic lens equator, is involved in eye formation.

Authors:  Hong Mu; Kunimasa Ohta; Sei Kuriyama; Naoko Shimada; Hidenobu Tanihara; Kunio Yasuda; Hideaki Tanaka
Journal:  Mech Dev       Date:  2003-02       Impact factor: 1.882

9.  Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.

Authors:  Alexey Bersenev; Chao Wu; Joanna Balcerek; Wei Tong
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein.

Authors:  P Lin; H Le-Niculescu; R Hofmeister; J M McCaffery; M Jin; H Hennemann; T McQuistan; L De Vries; M G Farquhar
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  2 in total

1.  The genetic architecture of the genome-wide transcriptional response to ER stress in the mouse.

Authors:  Clement Y Chow; Xu Wang; David Riccardi; Mariana F Wolfner; Andrew G Clark
Journal:  PLoS Genet       Date:  2015-02-04       Impact factor: 5.917

2.  Transcriptional Signatures of Tau and Amyloid Neuropathology.

Authors:  Isabel Castanho; Tracey K Murray; Eilis Hannon; Aaron Jeffries; Emma Walker; Emma Laing; Hedley Baulf; Joshua Harvey; Lauren Bradshaw; Andrew Randall; Karen Moore; Paul O'Neill; Katie Lunnon; David A Collier; Zeshan Ahmed; Michael J O'Neill; Jonathan Mill
Journal:  Cell Rep       Date:  2020-02-11       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.